New Data On Breast Imaging Using Cardiolite(R) To Be Presented At ASCO Breast Cancer

[News]

Lantheus Medical Imaging, a worldwide leader in diagnostic imaging, announced that the company's leading imaging agent, Cardiolite® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection) will be featured in a new study on molecular breast imaging being presented on Sunday, September 7, 2008, at 7:00am -12:00pm (EDT) as part of the poster sessions (abstract #68) at the American Society of Clinical Oncology's 2008 Breast Cancer Symposium in Washington, DC.

More... (http://www.medicalnewstoday.com/articles/120647.php)